4//SEC Filing
Lo Andrew 4
Accession 0000950170-25-064558
CIK 0001743881other
Filed
May 5, 8:00 PM ET
Accepted
May 6, 4:42 PM ET
Size
5.6 KB
Accession
0000950170-25-064558
Insider Transaction Report
Form 4
Lo Andrew
Director
Transactions
- Sale
Common Stock
2025-05-02$38.50/sh−100,000$3,849,900→ 105,583 total(indirect: By Andrew W. Lo and Nancy N. Lo JTWROS)
Holdings
- 48,099
Common Stock
Footnotes (1)
- [F1]Represents the weighted average sale price of the shares sold from $38.155 to $38.75 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
Documents
Issuer
BridgeBio Pharma, Inc.
CIK 0001743881
Entity typeother
Related Parties
1- filerCIK 0001679076
Filing Metadata
- Form type
- 4
- Filed
- May 5, 8:00 PM ET
- Accepted
- May 6, 4:42 PM ET
- Size
- 5.6 KB